Literature DB >> 10865202

How does antiresorptive therapy decrease the risk of fracture in women with osteoporosis?

P D Delmas.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10865202     DOI: 10.1016/s8756-3282(00)00301-x

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


× No keyword cloud information.
  19 in total

Review 1.  Biochemical markers of bone turnover in the clinical development of drugs for osteoporosis and metastatic bone disease: potential uses and pitfalls.

Authors:  Serge Cremers; Patrick Garnero
Journal:  Drugs       Date:  2006       Impact factor: 9.546

Review 2.  Bone remodeling markers: assessment of fracture risk and fracture risk reduction.

Authors:  Aubrey Blumsohn
Journal:  Curr Osteoporos Rep       Date:  2003-12       Impact factor: 5.096

3.  Pharmacologic treatment to prevent fractures: from markers to patients.

Authors:  Steven R Cummings
Journal:  Osteoporos Int       Date:  2009-05       Impact factor: 4.507

Review 4.  Update on bone density testing.

Authors:  E Michael Lewiecki
Journal:  Curr Osteoporos Rep       Date:  2005-12       Impact factor: 5.096

5.  Effects of salmon calcitonin on trabecular microarchitecture as determined by magnetic resonance imaging: results from the QUEST study.

Authors:  Charles H Chesnut; Sharmilla Majumdar; David C Newitt; Andrew Shields; Jan Van Pelt; Ellen Laschansky; Moise Azria; Audrey Kriegman; Melvin Olson; Erik F Eriksen; Linda Mindeholm
Journal:  J Bone Miner Res       Date:  2005-04-27       Impact factor: 6.741

Review 6.  Chronic kidney disease and bone fracture: a growing concern.

Authors:  Thomas L Nickolas; Mary B Leonard; Elizabeth Shane
Journal:  Kidney Int       Date:  2008-06-18       Impact factor: 10.612

7.  Effects of suppression of bone turnover on cortical and trabecular load sharing in the canine vertebral body.

Authors:  Senthil K Eswaran; Grant Bevill; Prem Nagarathnam; Matthew R Allen; David B Burr; Tony M Keaveny
Journal:  J Biomech       Date:  2009-01-31       Impact factor: 2.712

8.  Theoretical analysis of alendronate and risedronate effects on canine vertebral remodeling and microdamage.

Authors:  Xiang Wang; Antonia M Erickson; Matthew R Allen; David B Burr; R Bruce Martin; Scott J Hazelwood
Journal:  J Biomech       Date:  2009-03-12       Impact factor: 2.712

9.  Bisphosphonates alter trabecular bone collagen cross-linking and isomerization in beagle dog vertebra.

Authors:  M R Allen; E Gineyts; D J Leeming; D B Burr; P D Delmas
Journal:  Osteoporos Int       Date:  2007-12-18       Impact factor: 4.507

10.  Implications of local osteoporosis on the efficacy of anti-resorptive drug treatment: a 3-year follow-up finite element study in risedronate-treated women.

Authors:  D Anitha; K J Kim; S-K Lim; T Lee
Journal:  Osteoporos Int       Date:  2013-07-02       Impact factor: 4.507

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.